Abstract
Purpose
Hypoxic-ischemic brain injury that occurs in the perinatal period is one of the leading causes of mental retardation, visual and auditory impairment, motor defects, epilepsy, cerebral palsy, and death in neonates. The severity of apoptosis that develops after ischemic hypoxia and reperfusion is an indication of brain injury. Thus, it may be possible to prevent or reduce injury with treatments that can be given before the reperfusion period following hypoxia and ischemia. Levetiracetam is a new-generation antiepileptic drug that has begun to be used in the treatment of epilepsy.
Methods
The present study investigated the effects of levetiracetam on neuronal apoptosis with histopathological and biochemical tests in the early period and behavioral experiments in the late period.
Results
This study showed histopathologically that levetiracetam reduces the number of apoptotic neurons and has a neuroprotective effect in a neonatal rat model of hypoxic-ischemic brain injury in the early period. On the other hand, we demonstrated that levetiracetam dose dependently improves behavioral performance in the late period.
Conclusions
Based on these results, we believe that one mechanism of levetiracetam’s neuroprotective effects is due to increases in glutathione peroxidase and superoxide dismutase enzyme levels. To the best of our knowledge, this study is the first to show the neuroprotective effects of levetiracetam in a neonatal rat model of hypoxic-ischemic brain injury using histopathological, biochemical, and late-period behavioral experiments within the same experimental group.
Similar content being viewed by others
References
Wilkinson DJ (2009) Cool heads: ethical issues associated with therapeutic hypothermia for newborns. Acta Paediatr 98:217–20
Hill A (2006) Hypoxic-ischemic cerebral injury in the newborn. In: Swaiman KF, Ashwal S, Ferriero DM (eds). Pediatric neurology principles & practicer, 4th edn. Philadelphia, p 279–297
Mwaniki MK, Atieno M, Lawn JE, Newton CR (2012) Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 379:445–52
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365:663–70
Bonfold E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events, induced respectively by mild and intense insults with N methyl-dospartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 92:7162–6
Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D (2010) Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340:c363
Patsalos PN (2010) Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 85:77–85
Verrotti A, D’Adamo E, Parisi P, Chiarelli F, Curatolo P (2010) Levetiracetam in childhood epilepsy. Paediatr Drugs 12:177–86
Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707–24
Mazarati AM, Baldwin R, Klitgaard H, Matagne A (2004) Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 58:167–74
Hanon E, Klitgaard H (2001) Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10:287–93
Kim JS, Kondratyev A, Tomita Y, Gale K (2007) Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 48(suppl 5):19–26
Kilicdag H, Daglıoglu K, Erdogan S, Guzel A, Sencar L, Polat S, Zorludemir S (2013) The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 89:355–60
Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B (2011) Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 44:265–9
Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J (2011) Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol 15:1–7
Rice JE, Vanucci RC, Brierley JB (1981) The influence of immaturity on hypoxic–ischemic brain damage in the rat. Ann Neurol 9:131–41
Ikeda T, Mishima K, Yoshikawa T, Iwasaki K, Fujiwara M, Xia YX, Ikenoue T (2001) Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats. Behav Brain Res 118:17–25
Johnston MV, Fatemi A, Wilson MA, Northington F (2011) Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 10:372–82
Shalak L, Perlman JM (2004) Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 80:125–41
Jensen FE (1997) Perinatal hypoxic-ischemic brain injury: maturation-dependent relation to epilepsy. Ment Retard Dev Disabil Res Rev 3:85–95
Fan X, Kavelaars A, Heijnen CJ, Groenendaal F, van Bel F (2010) Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol 8:324–34
Glass HC, Ferriero DM (2007) Treatment of hypoxic-ischemic encephalopathy in newborns. Curr. Treat Options Neurol 9:414–23
Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 99:15089–94
Kabakus N, Ay I, Aysun S, Söylemezoglu F, Ozcan A, Celasun B (2005) Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats. J Child Neurol 20:582–7
Liu C, Lin N, Wu B, Qiu Y (2009) Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res 1282:173–82
Costa C, Martella G, Picconi B, Prosperetti C, Pisani A, Di Filippo M, Pisani F, Bernardi G, Calabresi P (2006) Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 37:1319–26
Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D (2008) Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol 11:321–9
Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim HJ, Kim H, Eun BL (2006) Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201:470–8
Yamada T, Yoneyama Y, Sawa R, Araki T (2003) Effects of maternal oxygen supplementation on fetal oxygenation and lipid peroxidation following a single umbilical cord occlusion in fetal goats. J Nihon Med Sch 70:165–71
Bågenholm R, Nilsson UA, Kjellmer I (1997) Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res 773:132–8
Kumar A, Ramakrishna SV, Basu S, Rao GR (2008) Oxidative stress in perinatal asphyxia. Pediatr Neurol 38:181–5
Oliveira AA, Almeida JP, Freitas RM, Nascimento VS, Aguiar LM, Júnior HV, Fonseca FN, Viana GS, Sousa FC, Fonteles MM (2007) Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cell Mol Neurobiol 27:395–406
Marini H, Costa C, Passaniti M, Esposito M, Campo GM, Ientile R, Adamo EB, Marini R, Calabresi P, Altavilla D, Minutoli L, Pisani F, Squadrito F (2004) Levetiracetam protects against kainic acid-induced toxicity. Life Sci 74:1253–64
Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S, Yager J (2009) Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 40:215–26
Ueda Y, Doi T, Takaki M, Nagatomo K, Nakajima A, Willmore LJ (2009) Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 1266:1–7
Katz I, Kim J, Gale K, Kondratyev A (2007) Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494–500
Fürwentsches A, Bussmann C, Ramantani G, Ebinger F, Philippi H, Pöschl J, Schubert S, Rating D, Bast T (2010) Levetiracetamin the treatment of neonatal seizures: a pilot study. Seizure 19:185–9
Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR (2011) Levetiracetam for treatment of neonatal seizures. J Child Neurol 26:465–70
Acknowledgments
This work was supported by the Mersin University Scientific and Research Foundation [BAP-TF. DTB (MK) 2011-5(TU)].
Conflict of interest
The authors declare that they have no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Komur, M., Okuyaz, C., Celik, Y. et al. Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. Childs Nerv Syst 30, 1001–1009 (2014). https://doi.org/10.1007/s00381-014-2375-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-014-2375-x